Refine by
Test Reagent Articles & Analysis
2 articles found
INOVIQ Ltd (ASX:IIQ) has successfully completed a feasibility study to evaluate the use of SubB2M as an immunohistochemistry (tissue-based test) reagent to aid in discriminating between benign skin lesions, malignant and metastatic melanoma. ...
Eight candidate vaccines are already being tested in people in clinical trials. Once an effective vaccine (or vaccines) has been identified, it will need to be produced rapidly and on a massive scale—billions of doses. ...